abstracts

0

Page précédente

Abstracts Lille 2003

Type présentation Jour N° Session N°communication Auteurs Titre Adresses
Poster Mercredi 16/04   16  P188 P Meshaka (1); N Mouchet (2); C Gaillez (1); S Sans (3); D Muzard (3); P Pinton (1); TREATMENT OF SEVERE SEPSIS WITH 2 ORGAN FAILURES – TEMPORARY AUTHORIZATION OF USE (TAU) OF XIGRIS IN ADULTS AND CHILDREN
Abstract complet
(1) Unité Thérapeutique Cardiologie, Infectiologie et Réanimation, Lilly France, SURESNES; (2) Département des Affaires Réglementaires, Lilly France, SURESNES; (3) Département de Pharmacovigilance, Lilly France, SURESNES;
Poster Mercredi 16/04   16  P189 K Lacut (1); E Oger (1); G Le Gal (1); F Couturaud (1); S Louis (2); C Leroyer (1); D Mottier (1); STATIN USE IS ASSOCIATED WITH A REDUCED RISK FOR VENOUS THROMBOEMBOLISM
Abstract complet
(1) Département de Médecine Interne et Pneumologie, CHU Cavale Blanche, BREST; (2) Unité d’Echo-Doppler, CHU Cavale Blanche, BREST;
Poster Mercredi 16/04   16  P190 S Dias (1); M Cucherat (1); E Amsallem (1); JP Boissel (1); ACCEPTABILITY BY GPS OF A NEW APPROACH OF KNOWLEDGE TRANSFER IN THERAPEUTICS
Abstract complet
(1) EA 643, Faculté de médecine RTH Laennec, LYON;
Poster Mercredi 16/04   16  P191 M Daurel-Receveur (1); S Picard (1); K Titier (1); D Ducint (1); F Pehourcq (1); N Moore (1); M Molimard (1); FULLY AUTOMATED ANALYTICAL METHOD FOR MYCOPHENOLIC ACID QUANTIFICATION IN HUMAN PLASMA USING ON-LINE SOLID PHASE EXTRACTION AND HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Abstract complet
(1) Laboratoire de pharmacologie clinique et de toxicologie, Université V. Segalen, CHU Pellegrin, BORDEAUX;
Poster Mercredi 16/04   16  P192 M Cucherat (1); E Amsallem (1); JP Boissel (1); TRIALYS : A KNOWLEDGE DATABASE OF CLINICAL TRIALS RESULTS
Abstract complet
(1) EA 643, Faculté de Médecine Laennec, LYON;
Poster Mercredi 16/04   16  P193 S Belgun – florea (1); S Briançon (2); J Doury (1); H Fessi (2); DEVELOPMENT OF A NEW PHARMACEUTICAL FORMULATION EFFECTIVE IN PREVENTION AND/OR TREATMENT OF DENTO-PERIODONTAL DISEASES
Abstract complet
(1) Laboratoire de recherche en santé publique (Lass – UMR 5823 CNRS), Faculté d’odontologie, 11 rue Guillaume Parradin, LYON; (2) Laboratoire d’Automatique et de Génie des Procédés (Lagep-UMR 5007CNRS), Univ. C. Bernard Lyon1, 43 bd du 11 novembre 1918, VILLEURBANNE;
Poster Mercredi 16/04   16  P194 AN Barkun (1); V Adam (2); W Kennedy (3); CA Fallone (1); K Herba (1); M Bardou (1); THE COST-EFFECTIVENESS OF HIGH DOSE ORAL VERSUS INTRAVENOUS PROTON PUMP INHIBITION IN HIGH-RISK PATIENTS WITH BLEEDING PEPTIC ULCERS HAVING UNDERGONE THERAPEUTIC ENDOSCOPY
Abstract complet
(1) Gastroenterology Department, McGill University Health Center, MONTREAL, CANADA; (2) Division of epidemiology, McGill University, MONTREAL, CANADA; (3) Faculté de pharmacie, Université de Montréal, MONTREAL, CANADA;
Poster Mercredi 16/04   16  P195 P Nicolas (1); B Uzzan (1); M Cucherat (2); JP Boissel (2); GY Perret (1); THE ROLE OF MICROVESSEL DENSITY (MVD) ON THE SURVIVAL OF PATIENTS WITH BREAST CARCINOMA : A SYSTEMATIC REVIEW OF THE LITERATURE WITH META-ANALYSIS
Abstract complet
(1) Lab Pharmacologie, Faculté de Médecine – CHU Bobigny, BOBIGNY; (2) Lab Pharmacologie, Faculté de Médecine – Université Lyon 1, LYON;

Page précédente